Market News & Trends
Bioadhesives Poised to Replace Synthetic Solutions
The global bioadhesive industry is rapidly gaining prominence due to the evolution of biomaterials and the benefits of bioadhesives in a host of applications across…
Patent Cliff Means Pharmaceutical Companies Will Lose $65 Billion by 2019
Pharmaceutical companies will suffer an estimated $65 billion drop in sales by 2019 due to the patent expiries of several leading drugs, according to research…
Stem Cell Therapies Gathering Momentum But Significant Challenges Remain
LONDON, UK (GlobalData), 9 December 2014 - With 104 programs in late-stage clinical development, the stem cell therapy space could reach the commercialization threshold by…
ABIVAX Successfully Completes First-in-Man Study of Small Molecule Targeting HIV
ABIVAX recently announced the successful completion of its Phase I first-in-man study of ABX464, which has been designed to potentially deliver a number of important…
CTI BioPharma Receives $15-Million Milestone
CTI BioPharma Corp. recently announced that it has received a $15-million milestone payment from Teva Pharmaceutical Industries Ltd. (Teva) related to the achievement of sales…
Catalent & Valerion Therapeutics to Collaborate
Catalent Pharma Solutions recently announced it is to collaborate with Valerion Therapeutics, LLC to develop Valerion’s two lead product candidates. The collaboration will focus on…
Hovione Files First IND Application With FDA
Hovione recenlty announced it has filed its first Investigational New Drug (IND) Application with the US FDA. This event represents a milestone in Hovione’s strategy…
Recipharm Acquires Flamel Technologies Sign Long-Term Collaboration
Recipharm AB (Jordbro) and Flamel Technologies SA (Lyon) recently announced they have entered into a long-term collaboration and signed an agreement whereby Recipharm will purchase…
Vetter Adds Flexible Serialization Service to its Portfolio
Vetter has recently announced a major milestone in the issue of drug safety. The contract development and manufacturing organization (CDMO) now offers the option of…
SciFluor Life Sciences Awarded US Patent for the Topical Treatment of Retinal Disease
Cambridge, Mass. (Dec. 4, 2014) - SciFluor Life Sciences, LLC, an emerging clinical-stage biopharmaceutical company that creates innovative therapeutics for patients with ophthalmologic and neurologic…
Horizon Discovery CEO Wins Executive of the Year Award
Cambridge, UK, 4th December 2014: Dr Darrin Disley, the Chief Executive Officer of Horizon Discovery Group plc (LSE: HZD) (Horizon), a leading provider of…
EMD Millipore Launches Kit for Analyzing NFкB Translocation by Imaging Flow Cytometry
Darmstadt, Germany, November 19, 2014 – EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today introduced the Amnis® NFкB Translocation kit,…
Age-Related Macular Degeneration Treatment Market Value to Exceed $10 Billion by 2023
LONDON, UK (GlobalData), 3 December 2014 - The Age-related Macular Degeneration treatment market across seven major countries (the US, UK, Germany, France, Spain, Italy and…
Global Market for Nucleic Acid Aptamers to Reach $5.4 Billion in 2019
Wellesley, Mass., December 3, 2014 – BCC Research (www.bccresearch.com) reveals in its latest report, Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets, the nucleic…
BioMarin & Prosensa Reach Agreement on Intended Public Offer for 100% of Prosensa's Outstanding Stock
BioMarin Pharmaceutical Inc. and Prosensa Holding N.V. recently announced they have entered into a definitive agreement in which BioMarin will offer to purchase all of…
Trimel Announces Exclusive License Agreement With Endo
Trimel Pharmaceuticals Corporation recently announced the signing of an agreement by its subsidiary, Trimel Biopharma SRL, providing an affiliate of Endo International plc with the…
MRC Technology & Yabao Pharmaceuticals Announce Exclusive Partnership
MRC Technology and Yabao Pharmaceutical Co, Inc. recently announced an exclusive license agreement to discover, develop, and commercialize innovative compounds targeting a specific kinase involved…
Noxilizer Expands Contract Sterilization Operations to Meet Rising Demand
Noxilizer, Inc. recently announced expansion of their contract sterilization operations, triggered by growing customer demand and increased industry acceptance of Noxilizer’s NO2 sterilization - a…
Juno T Cell Therapy Granted FDA Breakthrough Designation
Juno Therapeutics recently announced that the FDA has granted Breakthrough Therapy Designation to the company’s JCAR015 chimeric antigen receptor product candidate. The designation applies for…
Five Prime Therapeutics & Bristol-Myers Squibb Announce Exclusive Clinical Collaboration
Five Prime Therapeutics, Inc. and Bristol-Myers Squibb Company recently announced they have entered into an exclusive clinical collaboration agreement to evaluate the safety, tolerability, and…
